News & Views | Published:

Cancer

Pinprick diagnostics

Nature volume 486, pages 482483 (28 June 2012) | Download Citation

Rare tumour cells with mutations that confer drug resistance can go undetected by standard testing procedures, according to two studies, which show that such mutations can be detected in patients' blood. See Letters p.532 and p.537

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nature 486, 532–536 (2012).

  2. 2.

    et al. Nature 486, 537–540 (2012).

  3. 3.

    et al. Nature Methods 3, 551–559 (2006).

  4. 4.

    et al. Nature Med. 18, 221–223 (2012).

  5. 5.

    et al. Cancer Biol. Ther. 5, 928–932 (2006).

  6. 6.

    , & Nature Rev. Cancer 12, 323–334, (2012).

  7. 7.

    , , , & Sci. Transl. Med. 4, 127ps10 (2012).

  8. 8.

    et al. N. Engl. J. Med. 366, 883–892 (2012).

  9. 9.

    et al. Nature Med. 14, 985–990 (2008).

  10. 10.

    et al. Sci. Transl. Med. 4, 136ra68 (2012).

Download references

Author information

Affiliations

  1. Eduardo Vilar is in the Department of Clinical Cancer Prevention, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

    • Eduardo Vilar
  2. Tabernero is in the Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

    • Josep Tabernero

Authors

  1. Search for Eduardo Vilar in:

  2. Search for Josep Tabernero in:

Corresponding authors

Correspondence to Eduardo Vilar or Josep Tabernero.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/486482a

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing